Literature DB >> 17225035

Are clinical characteristics associated with upper-extremity hypertonia in severe ischaemic supratentorial stroke?

Annette A van Kuijk1, Henk T Hendricks, Jaco W Pasman, Berry H Kremer, Alexander C Geurts.   

Abstract

OBJECTIVE: The primary goal of this study was to identify clinical risk factors, in addition to muscle weakness, for upper-extremity hypertonia in patients with severe ischaemic supratentorial stroke. The secondary goal was to investigate the time course of upper-extremity hypertonia in these patients during the first 26 weeks post-stroke.
DESIGN: Inception cohort. PATIENTS: Forty-three consecutive patients with an acute ischaemic supratentorial stroke and an initial upper-extremity paralysis admitted to an academic hospital. PRIMARY OUTCOME: hypertonia assessed by the Ashworth scale at week 26 post-stroke. Potential risks factors: motor functions assessed by the upper-extremity subscore of the Fugl-Meyer motor assessment, Barthel Index at week 1, consciousness, sensory disturbances, apraxia, neglect, and hyper-reflexia. Secondary outcome: time course of upper-extremity hypertonia by assessing its prevalence at 6 consecutive moments post-stroke during a follow-up period of 26 weeks.
RESULTS: Twenty-five patients (63%) developed hypertonia during the follow-up period of 26 weeks. During this period, the prevalence of hypertonia followed a rather dynamic course, with cases of early, transient and late hypertonia. Univariate analyses yielded none of the selected clinical characteristics as significantly associated with hypertonia.
CONCLUSION: Despite the high incidence of hypertonia (63%) observed, none of the selected clinical characteristics could be identified as a risk factor for hypertonia.

Entities:  

Mesh:

Year:  2007        PMID: 17225035     DOI: 10.2340/16501977-0009

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  7 in total

1.  Abnormal spontaneous muscle activity in plegic limb appears to initiate distal to the upper motor neuron: a case report in a stroke patient.

Authors:  N Souayah; P Saadeh; N Krivitskaya; H W Sander
Journal:  J Vasc Interv Neurol       Date:  2013-02

2.  Gait improvement by low-dose botulinum toxin A injection treatment of the lower limbs in subacute stroke patients.

Authors:  Wu Tao; Dong Yan; Jian-Hua Li; Zhao-Hong Shi
Journal:  J Phys Ther Sci       Date:  2015-03-31

3.  Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.

Authors:  Han Gil Seo; Nam-Jong Paik; Shi-Uk Lee; Byung-Mo Oh; Min Ho Chun; Bum Sun Kwon; Moon Suk Bang
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

4.  Efficacy and safety of transcutaneous electrical acupoint stimulation to treat muscle spasticity following brain injury: a double-blinded, multicenter, randomized controlled trial.

Authors:  Wenli Zhao; Chao Wang; Zhongzheng Li; Lei Chen; Jianbo Li; Weidong Cui; Shasha Ding; Qiang Xi; Fan Wang; Fei Jia; Shuhua Xiao; Yi Guo; Ye Zhao
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

Review 5.  Incidence, Time Course and Predictors of Impairments Relating to Caring for the Profoundly Affected arm After Stroke: A Systematic Review.

Authors:  Rhoda Allison; Laura Shenton; Kathryn Bamforth; Cherry Kilbride; David Richards
Journal:  Physiother Res Int       Date:  2015-05-25

6.  Prevalence and Risk Factors for Spasticity After Stroke: A Systematic Review and Meta-Analysis.

Authors:  Huangling Zeng; Jian Chen; Yang Guo; Sheng Tan
Journal:  Front Neurol       Date:  2021-01-20       Impact factor: 4.003

7.  Evaluation of clinical outcomes of patients with post-stroke wrist and finger spasticity after ultrasonography-guided BTX-A injection and rehabilitation training.

Authors:  Li Jiang; Zu-Lin Dou; Qing Wang; Qiao-Yuan Wang; Meng Dai; Zhen Wang; Xiao-Mei Wei; Ying-Bei Chen
Journal:  Front Hum Neurosci       Date:  2015-09-02       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.